INSIGHTS ON CLINICAL TRIAL DESIGN

• How To Reduce Patient Dropout Rates In Clinical Trials

  Sponsors are addressing patient dropout rates by shifting from reactive troubleshooting to proactive protocol designs that minimize participant burden.

• Bring Your Own Device (BYOD) Clinical Trials

  Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.

• Why Is Clinical Trial Patient Travel So Important?

  Removing travel barriers in clinical trials ensures broader access, diverse participation and stronger results, benefiting both patients and researchers alike.

• Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions

  Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.

• Building Trust Through Connection: EmVenio At The Atlanta Black Expo

  5/19/2026

  Engaging with communities in familiar settings helps raise awareness, address concerns, and create a more inclusive foundation for clinical research participation built on dialogue, respect, and long‑term relationships.

• Cohort Configuration Feature Of An RTSM Platform

  3/16/2026

  Master trial agility by building and prioritizing cohorts in real time. Effortlessly manage dose levels and enrollment limits to keep your study on track, even as protocols evolve.

• RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters

  2/25/2026

  Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.

• Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients

  7/10/2026

  AI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.

• Delivering An Early-Phase Autoimmune Trial Across Regions

  11/6/2026

  Why do autoimmune trials stall when patients already have working treatments? See how one rare rheumatology study adapted its strategy to keep early-phase enrollment moving.